User Name 





« April 2014 »

The Maryland Psychiatric Society hosted a conference at Sheppard Pratt on March 23, 2013 entitled “Psychopharmacology - Updates, Advances & New Information”, for which I was asked to give a presentation about new developments concerning atypical antipsychotic agents. So I pondered. It had been a while since the newest triad of atypicals (asenapine, iloperidone, and lurasidone, in generic alphabetical order) made their appearance, and long-acting injectable paliperidone isn’t news anymore. I’d heard tha

At last, I have something in common with Michael Jordan and Brett Favre, or perhaps fortunately merely one thing in common. I have been called back from retirement. Devang Gandhi was kind enough to ask if I would rekindle my psychopharmacology column, and I decided to accept. This time around, however, I hope to maintain a slightly different focus.                  

Every Maryland resident is eligible to participate in the Maryland Rx Card program, which has no membership restrictions and no applications to fill out. It can be used by individuals with high deductible plans, or who do not qualify for public funded programs such as Medicaid and Medicare, or who receive medicines through charity care providers and require a drug that is not available to them. The card is accepted at over 56,000 regional and national pharmacies.

I will be using this month's column to describe the Medicaid Pharmacy Program, my role as P&T Committee member, and to solicit your comments and experiences with this system in anticipation of the upcoming August 21 P&T Committee meeting.

The 2008 Olympics are over, baseball is winding down, and football’s winding up. News reports of sports figures using performance-enhancing drugs to improve their odds against competitors have become almost routine and expected. However, little attention has been paid to the problem of using performance-enhancing psychotropics to improve cognitive abilities.

As the health care industry moves away from paper documents and processes and towards electronic versions, physicians have either embraced or shunned these changes. For many psychiatrists, these changes are irrelevant, because they are solo practitioners with no need to share their records. The billing may have gone electronic, and some of us use a computer to manage patient records, which are often just a collection of basic Word documents. However, many forces are pushing us to ad

On April 22, 2009 at Sheppard Pratt Hospital, a panel discussion chaired by Robert Roca, M.D. discussed “The Ethics of Placebo use.” This meeting was jointly sponsored by Med Chi, the Baltimore County Medical Association and the Maryland Psychiatric Society. Dr. Roca is Vice-President and Medical Director of Sheppard Pratt and serves as one of the MPS representatives to the APA Assembly.

 The Maryland Medicaid Program issued a new Preferred Drug List effective October 1, 2009. To view the updated list, please visit Please note that in a very small number of cases, the generic drug is not preferred and requires authorization through MedWatch, or the brand is also preferred and does not require authorization. Please direct questions or concerns to 410-767-1455.

    Home     Classified Ads     Contact MPS     Privacy Policy     Site Map